is a 2014-2018 Self Graduate Fellow pursuing a Ph.D. in medicinal chemistry. He received a B.A. in chemistry and a minor in entrepreneurship (2012) from Vanderbilt University in Nashville, Tennessee. During the course of his undergraduate studies, Orsi worked in a variety of laboratory environments, from working with gold nanopraticles in the Wright lab to biomedical materials with EIC Corporation. Prior to joining the medicinal chemistry program at KU, Orsi began shifting towards the pharmaceutical field, doing synthetic organic chemistry in the Makriyannis Lab at Northeastern University, isolating bioactive compounds at Aphios Pharmaceuticals, and finally synthesizing model systems for targeted cancer therapeutics in the Gamble Lab at the University of Otago in Dunedin, New Zealand. At KU, Orsi has joined the Altman Group, where he researches new synthetic methodology in organofluorine chemistry and small molecule approaches to overcoming resistance to antibacterials.
Mentor: Ryan A. Altman, Assistant Professor, Medicinal Chemistry